Zurich Insurance Sale of German Life Legacy Assets Won't Close As Planned
By David Sachs
Zurich Insurance Group said Tuesday that Viridium Group won't buy its legacy life insurance policy business in Germany as planned.
The Swiss insurance company had planned to sell Zurich Life Legacy to the German insurance platform since 2022. The transaction was meant to include the transfer of $20 billion in net reserves, mostly related to annuity and endowment products.
"Zurich is committed to finding a solution for this portfolio and will explore options in due course," Zurich said.
The company's financial targets nor capital management plans will be affected, Zurich said.
Write to David Sachs at david.sachs@wsj.com
Corrections & Amplifications
This article was corrected at 0941 GMT to clarify that Zurich Insurance Group said it has been informed that Viridium Group won't buy its life legacy business in Germany as planned. An earlier article incorrectly said Zurich had said the sale had been canceled.
(END) Dow Jones Newswires
January 30, 2024 02:36 ET (07:36 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Six Sports Betting and iGaming Stocks Trading at a Discount
-
4 Predictions for Stocks and the Economy for the Second Half of 2024
-
What Broadening Rally? AI Stocks Dominate Again In Q2
-
After Earnings, Is Nike Stock a Buy, a Sell, or Fairly Valued?
-
Worst-Performing Stock ETFs of the Quarter
-
Top-Performing Stock ETFs of the Quarter
-
Q2 In Review and Q3 2024 Market Outlook
-
5 Stocks to Buy for 3Q 2024
-
Industrials: Sector Offers Investment Opportunities as Performance Lags Broader Market
-
Consumer Defensives: Even Amid Macro Pressures, Deals Permeate the Landscape
-
33 Undervalued Stocks
-
Utilities: Can the Stocks Keep the Rally Going?
-
Basic Materials: Following Index Decline, We See Many Long-Term Opportunities
-
Healthcare: Valuations Look Attractive In Most Industries
-
Financial Services: Amid Uncertainties, We See the Most Value In Banks and Credit Services
-
Consumer Cyclicals: Even With Anxiety Over Spending, We See Attractive Valuations